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Nanoparticle-cell-nanoparticle communication by stigmergy was 
demostrated using two capped nanodevices. The first of 
nanoparticles (i.e. S(RA)IFN) is loaded with 9-cis-retinoic acid 
and capped with interferon-, whereas the second 
community of nanoparticles (i.e. S(sulf)PIC) is loaded with 
sulforhodamine B and capped with poly(I:C). The uptake of 
S(RA)IFN by SK-BR-3 breast cancer cells enhanced the 
expression of TLR3 receptor facilitating the subsequent 
uptake of S(sulf)PIC and cell killing. 
Despite the progress made in nanotechnology,
1
 there are 
still many challenges to be solved and there is a long way 
ahead in research and development before we realize its full 
potential. In particular, communication or cooperative 
behaviours at the nanoscale between nanodevices remains an 
almost unexplored topic. While new nanodevices are reported 
every year, communication and cooperation between them 
may expand the capabilities of single nanoparticles by allowing 
them to share information and to cooperate.
2
 
Chemical or molecular communication, based on 
transmitting and receiving information sharing molecules 
(chemical messengers), is essential at cellular level and 
represents one of the communication forms used by living 
organisms. Moreover, it has been demonstrated that 
molecular communication can also be established in 
communities of nanoparticles.
3
 In contrast to interaction 
mediated by direct interchange of chemical messengers, there 
are many examples in the nature where swarm systems 
communicate and cooperate by modifying the environment. 
This concept is called stigmergy.
4
 However, its full power 
remains underappreciated and examples using nanoparticles 
remains almost unexplored.  
In order to explore this stigmergy concept in cell-
nanoparticle communities it can be envisioned a first 
nanodevice acting as an allosteric activator, which is able to 
increase the cell ability to interact with a second wave of 
nanoparticles. In such mechanism, there is nanoparticle-cell-
nanoparticle communication through stigmergy; despite there 
is not communication through chemical messengers (therefore 
there is not mutual “awareness”) between the two 
communities of nanoparticles, they are able to act 
cooperatively (therefore communicate), overall developing a 
self-organizing activity. 
 As a proof of concept, we describe here the use of gated 




materials are nanoscopic devices in which the release of 
molecules, biomolecules or nano-objects from a porous matrix 
can be triggered by a target external stimulus.
7
 In the last few 
year gated nano-containers, most of them based in the use of 
mesoporous silica nanoparticles (MSNs), have proved to be 
excellent candidates for the design of nanomachines at 
different levels and for different applications.
8-13
 
 Part of our approach is based in the use of polyinosinic-
polycytidylic acid (poly(I:C)), a synthetic dsRNA agonist of TLR3 
that is known to induce direct inhibition of tumour growth in 
different cancer cell models. Currently, several ligands for TLR3 
are being evaluated in different clinical trials. A general 
consequence of TLR3-ligands interactions is an intense 
inflammatory response. Moreover, the induction of apoptotic 
mechanisms has also been observed in several cancers, 
through extrinsic pathways that lead to the final activation of 
effector caspases like caspase 3.
14,15
 Hence, targeting TLR3 
receptor is an effective strategy to treat different malignancies 
expressing TLR3. 
 Another concept we have used is the use of 9-cis-retionic 
acid (RA) and interferon- (IFN) which are molecules known to 
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Scheme 1. a) The mechanism of action of the cooperative nanosystems. 1. S(RA)IFN nanoparticles interact with IFN receptor on the cell 
membrane; 2. IFN signalling activates IRF-1 and STAT-1 transcription factors; 3. S(RA)IFN nanoparticles are endocyted; 4. IFN capping moieties on 
S(RA)IFN nanoparticles surface are degraded by lysosomal enzymes, allowing the release of RA from the mesopores; 5. RA signalling also activates 
IRF-1 and STAT-1; 6. TLR3 expression is induced; 7. enhanced interaction of S(sulf)PIC nanoparticles with TLR3; 8. TLR3 activates extrinsic 
apoptotic pathways that lead to cell death. b) A schematic representation of S(RA)IFN and S(sulf)PIC nanoparticles. 
 
The stigmergy cooperation protocol is based on the use of two 
sets of capped MSNs. The first community of MSNs (S(RA)IFN) is 
loaded with 9-cis-retionic acid and capped with an interferon- 
derivative, whereas in the second community (S(sulf)PIC) the 
payload is sulforhodamine B and the nanoparticles are capped with 
poly(I:C) (Scheme 1b). The cooperative behaviour of the two 
sets of nanoparticles is tested using SK-BR-3 cancer cells. The 
interaction of the capping interferon- on S(RA)IFN with its 
receptor located in the membrane of SK-BR-3 cells, induces both an 
upregulation of TLR3 expression and the internalization of the 
nanoparticles. Consequently, the release of of 9-cis-retinoic acid 
due to the degradation of the gating ensemble by the 
lysosomal enzymes takes place. The released molecules are also 
expected to induce a marked enhancement in TLR3 expression in 
SK-BR-3 cells. Poly(I:C) in the second set of nanoparticles is known 
to strongly interact with TLR3, and this is expected to have a 
cytotoxic effect as consequence of the activation of apoptotic 
signalling pathways. In this combination the first community of 
nanoparticles performs an action (induction of TLR3 expression) 
and the trace of this action (a larger number of TLR3 receptors) 
stimulates the performance of the second community of 
nanoparticles (Scheme 1a).  
MSNs were prepared using well-known procedures. The 
pores of the calcined MSNs were loaded with 9-cis-retinoic 
acid and the external surface functionalized with 
propylisocyanate moieties (solid S(RA)NCO). Then, interferon- 
was attached onto the external surface of S(RA)NCO, by means 
of the formation of urea bonds, yielding the final nanoparticles 
S(RA)IFN. In order to test the gating mechanism, similar 
nanoparticles but loaded with sulforhodamine B were also 
prepared (S(sulf)IFN). For the preparation of the second 
community of nanoparticles, MSNs were loaded with 
sulforhodamine B and the external surface decorated with 
aminopropyl moieties (S(sulf)NH2). Finally, the pores were 
capped upon reaction of the activated phosphate groups of 
poly(I:C) with the aminopropyl moieties grafted onto the 
external surface yielding S(sulf)PIC. The prepared nanoparticles 
were characterized using standard procedures (see Supporting 
Information for details). Moreover, sulforhodamine B release 
from S(sulf)IFN and S(sulf)PIC in the presence of lysosomal 
extract was tested (Figure 1). As can be seen, sulforhodamine 
B release from solid S(sulf)IFN and S(sulf)PIC was low in the 
absence of the extract (release < 15 % of maximum release 
after 25 h), which indicates the correct capping of the material 
by the bulky interferon- (in S(sulf)IFN) and poly(I:C) (in 
S(sulf)PIC). In contrast, a remarkable cargo release occurred for 
both solids in the presence of lysosomal extract. This is 
attributed to enzymatic degradation of the interferon-γ and 
poly(I:C) caps, which induced sulforhodamine B release. 









, Cys, GSH, H2O2) or changes in the pH (4, 7 and 9) did not 
induce sulforhodamine release from S(sulf)IFN and S(sulf)PIC 
nanoparticles (Figure SI-3).  
Cell viability assays with both S(RA)IFN and S(sulf)PIC solids 
were carried out. The underlying idea was to compare the 
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cytotoxic effect exerted by poly(I:C) in SK-BR-3 cells using 
S(sulf)PIC nanoparticles alone or in combination with a pre-
treatment with S(RA)IFN. Besides, in order to highlight the 
cooperation between nanoparticles, viability assays with free 
poly(I:C) and poly(I:C) combined with free 9-cis-retinoic acid 
and interferon-, at the same concentrations as in the 
nanoparticles, were also carried out. The obtained results are 
presented in Figure 2a that shows dose-response curves after 
48 h experiments carried out with S(sulf)PIC alone (using the 
required amounts of nanoparticles to reach a poly(I:C) 
concentration in the 0.001-500 g mL
-1
 range) or treatment 
with S(sulf)PIC after 4 h pre-treatment with S(RA)IFN solid. For 
S(RA)IFN it was used the appropriate quantity of nanoparticles 
to obtain a 9-cis-retinoic acid concentration of 0.3 g mL
-1
. 
Moreover, Figure 2a also shows the curves obtained when 
cells are treated with poly(I:C) alone or treated with poly(I:C) 
after 4 h pre-treatment of the cells with 9-cis-retionic acid (0.3 
μg mL
-1
) and interferon- (15 ng mL
-1
). As shown in Figure 2a, 
free poly(I:C) cytotoxicity on SK-BR-3 cells is negligible at the 
tested concentrations, while it is only slightly enhanced after 
pre-treatment with free 9-cis-retinoic acid and interferon-, 
pointing out the importance of the nanoformulation when 
data is compared with the treatment using S(sulf)PIC or S(RA)IFN 
+ S(sulf)PIC combination (vide infra). 
Figure 1. Cargo delivery profiles from solids (a) S(sulf)IFN and (b) 
S(sulf)PIC, in the absence and in the presence of lysosomal extract. 
 
To confirm the TLR3-mediated S(sulf)PIC nanoparticles 
internalization confocal microscopy measurements were carried 
out. SK-BR-3 cell cultures were treated for 48 h with S(sulf)PIC (50 μg 
mL
-1
 of equivalent poly(I:C)). A clear sulforhodamine B fluorescence 
was observed in the cytosol of SK-BR-3 cells treated with S(sulf)PIC, 
indicating internalization of nanoparticles and subsequent 
uncapping and dye release in the lysosomes (Figure 3). 
Most interestingly, when SK-BR-3 cells were pre-treated with 
S(RA)IFN and then incubated with S(sulf)PIC, a remarkable decrease 
in cells viability, when compared to that obtained when using 
S(sulf)PIC alone, was observed. For example, at 25 g mL
-1
 poly(I:C) 
concentration, cell viability was reduced from 90% to 65% when 
treated with S(sulf)PIC alone or with both S(RA)IFN+S(sulf)PIC 
nanoparticles, respectively. Overall S(RA)IFN and S(sulf)PIC 
nanoparticles act cooperatively by stigmergy. The first community 
of nanoparticles (i.e. S(RA)IFN) perform an action (delivery of 
interferon- and 9-cis-retinoic that act as chemical cues that 
enhance the overexpression of membrane TLR3 receptors) and the 
trace of this action (enhanced expression of TLR3 receptors) 
stimulates the performance of the second community of 
nanoparticles (i.e. S(sulf)PIC) that are more effectively internalized 
and enhanced cell killing. This was confirmed by Western blot 
assays (Figure 2b) that demonstrated the induction of TLR3 



















Figure 2. (a) Dose-response curves after 48 h for cells treated with free 
poly(I:C), with 9-cis-retinoic acid and interferon- for 4 h and then with 
poly(I:C), with S(sulf)PIC and, finally, with S(RA)IFN for 4 h and then with 
S(sulf)PIC. Cell viability was determined by using the cell proliferation 
reagent WST-1. Concentrations between 0.001 and 500 μg mL-1 of free 
poly(I:C) and equivalent poly(I:C) in S(sulf)PIC were tested. 15 ng mL
-1 of 
interferon- and 0.3 μg mL-1 of 9-cis-retinoic acid and equivalent 9-cis-
retinoic acid in S(RA)IFN were used. All values are shown as the mean ± 
SD (n=3). Asterisks indicate significant differences (*= p < 0.01, **= p < 
0.001) when t test was applied. (b) Representative immunoblots 
showing induction of TLR3 in SK-BR-3 cells after a 24 h treatment with 
free 9-cis-retinoic acid (0.3 μg mL-1) and interferon- (15 ng mL-1) or 
with S(RA)IFN. Relative expression of TLR3 was calculated by 
densitometry, normalizing by the loading control (α-Tubulin). 
Expression values are shown as the mean ± SD (n=3). Asterisks indicate 
significant differences (*= p < 0.001, **= p < 0.0001) when t test was 
applied. 
 
We also carried out additional viability experiments using flow 
cytometry at an equivalent concentration of poly(I.C) of 500 




 was also used. Similar 
results to those obtained in Figure 2a for the same poly(I:C) 
concentration were found (Figure 4). Thus, the viability of SK-
BR-3 cells treated with poly(I:C), interferon-+ 9-cis-retinoic 
acid and poly(I:C) + interferon-+ 9-cis-retinoic remained 
virtually unchanged. A moderate reduction to ca. 55% viability 
was observed when SK-BR-3 cells were treated with a mixture 
of interferon- and 9-cis-retinoic and then administered with 
S(sulf)PIC or with the nanoparticles alone (viability ca. 60%). 
However, when cells were treated with TLR3 inhibitor and 
S(sulf)PIC, cell viability increased to ca. 80%. This enhancement 
in viability is consistent with the blockage of TLR3 receptor by 
the inhibitor and, as a consequence, the reduced uptake of 
S(sulf)PIC nanoparticles. Besides, in these flow cytometry 
studies a marked reduction in SK-BR-3 cells viability (to ca. 
20%) was observed when both nanoparticles were 
administered sequentially, thus reinforcing the stigmergy 
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Figure 3. Internalization and release of sulforhodamine B (red) in SK-
BR-3 cells. Cultures were incubated with S(sulf)PIC for 48 h and 
examined by confocal microscopy. Cells nuclei were stained with DAPI 
(blue) before microscope observation. Representative images for 
phase contrast (PhC, a, e), DAPI (b, f), sulforhodamine B (sulf, c, g) and 













Figure 4. Analysis of cell viability by flow cytometry. A concentrations 
of 500 μg mL-1 of free poly(I:C) and equivalent poly(I:C) in S(sulf)PIC was 
tested. 15 ng mL-1 of interferon- and 0.3 μg mL-1 of 9-cis-retinoic acid 
and equivalent 9-cis-retinoic acid in S(RA)IFN were used. Data 
represents the mean ± SD (n=3). Asterisks indicate significant 
differences (*= p < 0.001, **= p < 0.0001) when t test was applied. 
 
 In summary, we present here a proof of concept of a 
nanoparticle-cell-nanoparticle communication model involving 
two nanodevices. The first set of nanoparticles are loaded with 
9-cis-retinoic acid and capped with interferon- (S(RA)IFN), 
whereas in the second nanodevice sulforhodamine B was used 
as cargo and poly(I:C) chains as caps (S(sulf)PIC). The uptake of 
S(RA)IFN by SK-BR-3 breast cancer cells enhanced the 
overexpression of TLR3 receptor that facilitated the 
subsequent internalization of S(sulf)PIC. As a consequence, a 
marked reduction in cells viability was observed when both 
communities of nanoparticles were used in a combined 
treatment, compared to that obtained with S(sulf)PIC alone or 
by a combination of free 9-cis-retinoic, interferon- and 
poly(I:C). The results presented in this work demonstrate the 
possibility of developing stigmergy 
communication/cooperation strategies involving communities 
of nanodevices and cells. Such stigmergy protocols may 
enhance nanocarrier outcomes and potentiate their 
applications in targeted transport and drug delivery, opening 
wide new scenarios of cooperation/communication between 
nanoparticles and leading to the design of a number of 
plausible networks with the aim to increase drug efficacy and 
to reduce dosages, side effects, and resistance.  
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